Position in ESPR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
11,394,833
-4.3% QoQ
Ownership
4.43%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Two Seas Capital LP holds $142,763,597 across 1 Drug Manufacturers - Specialty & Generic name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,479,493 | $142,763,597 |
All Filings in ESPR
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 11,394,833 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 11,902,521 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | — | 9,749,724 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | — | 9,954,975 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $9,755,875 | 9,954,975 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | — | 6,930,871 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | — | 6,230,871 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | — | 6,584,278 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | — | 5,735,660 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | — | 4,165,657 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | — | 7,686,120 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | — | 7,672,170 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | — | 2,941,872 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||